Published Jun 28, 2021
#498 Dexcom G7 Talk With Dexcom CEO Kevin Sayer
Kevin Sayer, CEO of Dexcom, delves into the technological and strategic innovations of the Dexcom G7, including its integration with insulin pumps, partnerships with tech giants, and transition to pharmacy distribution, all designed to enhance diabetes management and accessibility.
Topics covered
Popular Clips
Questions from this episode
Episode Highlights
Related Episodes
#116 Dexcom Update with CEO Kevin Sayer
Answers 383 questions#234 Dexcom CEO Kevin Sayer Returns
Answers 383 questions
#806 Dexcom G7 Approved By FDA (with Dexcom COO Jake Leach)
Answers 383 questions#158 Dexcom G6 Overview With Dexcom President Kevin Sayer
Answers 383 questions#694 Dexcom CEO chats from ADA 2022
Answers 383 questions#676 Dexcom G7 is Getting Close
Answers 383 questions#418 Dexcom G7 Update
Answers 383 questions#510 Dexcom G7 App Refresh with Dexcom CTO
Answers 383 questions
#768 Dexcom G7 Design
Answers 383 questions#954 Dexcom COO Jake Leach: G7, G6, Type 2 and your Questions
Answers 383 questions#345 Dexcom CEO Returns
Answers 383 questions
#782 Dexcom G7 User
Answers 383 questions
#194 Dexcom Returns
Answers 383 questions
#309 Omnipod and Dexcom Updates
Answers 383 questions
#213 NEW Dexcom G6 Mobile App (Now With Siri)
Answers 383 questions